• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体作为骨肉瘤中高效的纳米载体:生物学功能及潜在临床应用

Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications.

作者信息

Yang Lingkai, Huang Xin, Guo Haoyu, Wang Lutong, Yang Wenbo, Wu Wei, Jing Doudou, Shao Zengwu

机构信息

Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Cell Dev Biol. 2021 Oct 12;9:737314. doi: 10.3389/fcell.2021.737314. eCollection 2021.

DOI:10.3389/fcell.2021.737314
PMID:34712664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546119/
Abstract

Osteosarcoma is the most common bone tumor affecting both adolescents and children. Although localized osteosarcoma has an overall survival of >70% in the clinic, metastatic, refractory, and recurrent osteosarcoma have poorer survival rates. Exosomes are extracellular vesicles released by cells and originally thought to be a way for cells to discard unwanted products. Currently, exosomes have been reported to be involved in intercellular cross-talk and induce changes in cellular behavior by transferring cargoes (proteins, DNA, RNA, and lipids) between cells. Exosomes regulate osteosarcoma progression, and processes such as tumorigenesis, proliferation, metastasis, angiogenesis, immune evasion, and drug resistance. Increasing evidences shows that exosomes have significant potential in promoting osteosarcoma progression and development. In this review, we describe the current research status of exosomes in osteosarcoma, focusing on the biological functions of osteosarcoma exosomes as well as their application in osteosarcoma as diagnostic biomarkers and therapeutic targets.

摘要

骨肉瘤是影响青少年和儿童的最常见骨肿瘤。尽管局限性骨肉瘤在临床上的总生存率>70%,但转移性、难治性和复发性骨肉瘤的生存率较低。外泌体是细胞释放的细胞外囊泡,最初被认为是细胞丢弃不需要产物的一种方式。目前,据报道外泌体参与细胞间通讯,并通过在细胞间传递货物(蛋白质、DNA、RNA和脂质)诱导细胞行为改变。外泌体调节骨肉瘤的进展以及肿瘤发生、增殖、转移、血管生成、免疫逃逸和耐药性等过程。越来越多的证据表明,外泌体在促进骨肉瘤进展和发展方面具有巨大潜力。在本综述中,我们描述了外泌体在骨肉瘤中的当前研究现状,重点关注骨肉瘤外泌体的生物学功能及其在骨肉瘤中作为诊断生物标志物和治疗靶点的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/343c2bb1674d/fcell-09-737314-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/1c28aed5107e/fcell-09-737314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/4695f67c509f/fcell-09-737314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/c12dc2620717/fcell-09-737314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/0d84d3965a66/fcell-09-737314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/343c2bb1674d/fcell-09-737314-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/1c28aed5107e/fcell-09-737314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/4695f67c509f/fcell-09-737314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/c12dc2620717/fcell-09-737314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/0d84d3965a66/fcell-09-737314-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f9e/8546119/343c2bb1674d/fcell-09-737314-g005.jpg

相似文献

1
Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications.外泌体作为骨肉瘤中高效的纳米载体:生物学功能及潜在临床应用
Front Cell Dev Biol. 2021 Oct 12;9:737314. doi: 10.3389/fcell.2021.737314. eCollection 2021.
2
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions.转移性骨肉瘤细胞的外泌体通讯可将肺泡巨噬细胞调节为促进肿瘤的M2表型,并抑制其杀瘤功能。
Oncoimmunology. 2020 Apr 12;9(1):1747677. doi: 10.1080/2162402X.2020.1747677. eCollection 2020.
3
Exosomes in Bone Cancer: Unveiling their Vital Role in Diagnosis, Prognosis, and Therapeutic Advancements.骨癌中的外泌体:揭示它们在诊断、预后及治疗进展中的重要作用
J Cancer. 2024 Jun 3;15(13):4128-4142. doi: 10.7150/jca.95709. eCollection 2024.
4
Exosomes in Bone Sarcomas: Key Players in Metastasis.骨肉瘤中的外泌体:转移的关键参与者。
Cells. 2020 Jan 17;9(1):241. doi: 10.3390/cells9010241.
5
Exosomes in gastric cancer: roles, mechanisms, and applications.胃癌中的细胞外囊泡:作用、机制与应用。
Mol Cancer. 2019 Mar 15;18(1):41. doi: 10.1186/s12943-019-1001-7.
6
Functions and therapeutic potentials of exosomes in osteosarcoma.骨肉瘤中外泌体的功能及治疗潜力
Acta Mater Med. 2022 Oct 18;1(4):552-562. doi: 10.15212/amm-2022-0024. Epub 2022 Dec 30.
7
Role of exosomal miR‑21 in the tumor microenvironment and osteosarcoma tumorigenesis and progression (Review).外泌体 miR-21 在肿瘤微环境及骨肉瘤发生发展中的作用(综述)。
Int J Oncol. 2020 May;56(5):1055-1063. doi: 10.3892/ijo.2020.4992. Epub 2020 Feb 19.
8
Information Transfer and Biological Significance of Neoplastic Exosomes in the Tumor Microenvironment of Osteosarcoma.骨肉瘤肿瘤微环境中肿瘤外泌体的信息传递及生物学意义
Onco Targets Ther. 2020 Sep 8;13:8931-8940. doi: 10.2147/OTT.S266835. eCollection 2020.
9
Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential.探讨外泌体 cargo 对骨肉瘤进展的影响:治疗潜力的深入了解。
Int J Mol Sci. 2024 Jan 1;25(1):568. doi: 10.3390/ijms25010568.
10
The role of exosomes in lung cancer metastasis and clinical applications: an updated review.外泌体在肺癌转移中的作用及其临床应用:最新综述。
J Transl Med. 2021 Jul 19;19(1):312. doi: 10.1186/s12967-021-02985-1.

引用本文的文献

1
The therapeutic potential of exosomes in bone cancers: osteosarcoma, chondrosarcoma, and Ewing sarcoma.外泌体在骨癌(骨肉瘤、软骨肉瘤和尤文肉瘤)中的治疗潜力。
Invest New Drugs. 2025 Jul 5. doi: 10.1007/s10637-025-01551-6.
2
Bioinspired nanomedicines for the management of osteosarcoma: Recent progress and perspectives.用于骨肉瘤治疗的仿生纳米药物:最新进展与展望
Mater Today Bio. 2025 Mar 5;32:101607. doi: 10.1016/j.mtbio.2025.101607. eCollection 2025 Jun.
3
Osteosarcoma Exosome Priming of Primary Human Lung Fibroblasts Induces an Immune Modulatory and Protumorigenic Phenotype.

本文引用的文献

1
Exosomes in osteosarcoma research and preclinical practice.骨肉瘤研究与临床前实践中的外泌体
Am J Transl Res. 2021 Mar 15;13(3):882-897. eCollection 2021.
2
Osteosarcoma Cell-Derived Exosomal miR-1307 Promotes Tumorgenesis via Targeting AGAP1.骨肉瘤细胞来源的外泌体 miR-1307 通过靶向 AGAP1 促进肿瘤发生。
Biomed Res Int. 2021 Mar 25;2021:7358153. doi: 10.1155/2021/7358153. eCollection 2021.
3
Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.巨噬细胞来源的外泌体长链非编码RNA LIFR-AS1通过miR-29a/NFIA轴促进骨肉瘤细胞进展。
骨肉瘤外泌体对原代人肺成纤维细胞的预处理可诱导免疫调节和促肿瘤表型。
Cancer Res Commun. 2025 Apr 1;5(4):594-608. doi: 10.1158/2767-9764.CRC-24-0371.
4
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy.体内基因编辑和嵌合抗原受体细胞的原位生成用于下一代癌症免疫疗法。
J Hematol Oncol. 2024 Nov 13;17(1):110. doi: 10.1186/s13045-024-01633-7.
5
Bioinspired nanovesicles released from injectable hydrogels facilitate diabetic wound healing by regulating macrophage polarization and endothelial cell dysfunction.受生物启发的纳米囊泡从可注射水凝胶中释放出来,通过调节巨噬细胞极化和内皮细胞功能障碍促进糖尿病伤口愈合。
J Nanobiotechnology. 2023 Oct 3;21(1):358. doi: 10.1186/s12951-023-02119-3.
6
Stem cell-based drug delivery strategy for skin regeneration and wound healing: potential clinical applications.基于干细胞的皮肤再生与伤口愈合药物递送策略:潜在的临床应用
Inflamm Regen. 2023 Jun 30;43(1):33. doi: 10.1186/s41232-023-00287-1.
7
Exosomes and osteosarcoma drug resistance.外泌体与骨肉瘤耐药性。
Front Oncol. 2023 Mar 17;13:1133726. doi: 10.3389/fonc.2023.1133726. eCollection 2023.
8
Advances in the Study of Exosomes as Drug Delivery Systems for Bone-Related Diseases.外泌体作为骨相关疾病药物递送系统的研究进展
Pharmaceutics. 2023 Jan 9;15(1):220. doi: 10.3390/pharmaceutics15010220.
9
Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors.耐药性:外泌体 miRNA 在造血肿瘤微环境中的作用。
Molecules. 2022 Dec 23;28(1):116. doi: 10.3390/molecules28010116.
10
Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.整合批量RNA测序和单细胞RNA测序数据以揭示骨肉瘤的免疫微环境和代谢模式。
Front Genet. 2022 Oct 19;13:976990. doi: 10.3389/fgene.2022.976990. eCollection 2022.
Cancer Cell Int. 2021 Apr 1;21(1):192. doi: 10.1186/s12935-021-01893-0.
4
Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.细胞外囊泡:一种新兴的癌症治疗纳米平台。
Front Oncol. 2021 Feb 8;10:606906. doi: 10.3389/fonc.2020.606906. eCollection 2020.
5
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes.Rab22a-NeoF1 融合蛋白通过其分泌进入外泌体促进骨肉瘤肺转移。
Signal Transduct Target Ther. 2021 Feb 11;6(1):59. doi: 10.1038/s41392-020-00414-1.
6
H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.H3K27 乙酰化激活的 COL6A1 通过抑制 STAT1 和激活肺肿瘤相关成纤维细胞促进骨肉瘤肺转移。
Theranostics. 2021 Jan 1;11(3):1473-1492. doi: 10.7150/thno.51245. eCollection 2021.
7
Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner.顺铂耐药骨肉瘤细胞衍生的外泌体以依赖外泌体 circ_103801 的方式将顺铂耐药性赋予受体细胞。
Cell Biol Int. 2021 Apr;45(4):858-868. doi: 10.1002/cbin.11532. Epub 2020 Dec 25.
8
Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway.外泌体介导的 Hic-5 通过 Wnt/β-catenin 信号通路调节骨肉瘤的增殖和凋亡。
Aging (Albany NY). 2020 Dec 13;12(23):23598-23608. doi: 10.18632/aging.103546.
9
LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis.长链非编码RNA CASC15在骨肉瘤血浆外泌体中上调,敲低CASC15通过调节miR-338-3p/RAB14轴抑制骨肉瘤进展。
Onco Targets Ther. 2020 Nov 23;13:12055-12066. doi: 10.2147/OTT.S282053. eCollection 2020.
10
Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3.肿瘤来源的外泌体通过 Tim-3 诱导 M2 型巨噬细胞极化并促进骨肉瘤细胞的转移。
Arch Med Res. 2021 Feb;52(2):200-210. doi: 10.1016/j.arcmed.2020.10.018. Epub 2020 Nov 5.